Stockreport

PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning [Yahoo! Finance]

CACI International, Inc. Class A  (CACI) 
Last caci international, inc. class a earnings: 4/29 04:15 pm Check Earnings Report
US:NYSE Investor Relations: investor.caci.com
PDF Diagnostics "Urine-Based Machine Learning Assay Detects Prostate Cancer," demonstrating clinical validation of its PanGIA Analysis System ("PAS") platform, a urine-based [Read more]